ASTX727 LD

cedazuridine + decitabine · Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASTX727 LD, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS [Phase 1, Phase 2]